See the
Difference

Lyophilized amnion for clinical and surgical vision applications

The XcellerEYES™ is the only Lyophilized Ophthalmic Membrane in the market today. It performs similarly to cryopreserved tissue with the application and storage benefits of dehydrated membranes.

Better Preserved Matrix
Optimal ECM Preservation
Convenient Ambient Temperature Storage

Multiple Sizes Available

Product Details

XcellerEYES

Testimonials

Listen to what physicians are saying about XcellerEYES.

Joaquin De Rojas, MD

Director of Ocular Surface Disease and Cornea

“It combines the best of both dehydrated and cryopreserved membranes when you consider ease-of-use, storage, patient tolerance and corneal healing, which is why I was really interested in XcellerEYES.”

Pryia Mathews, MD

Cataract, Cornea, and Refractive Surgeon

“XcellerEYES membranes are my ‘go-to’ amniotic membrane now.“

Artificial Intelligence Applications and Performance Metrics in Ophthalmology: A Systematic Review and Meta-Analysis

Wound Care

Chronic Wound Management: From Gauze to Homologous Cellular Matrix

Implementing Technology in Practice: Factors Associated with Clinicians’ Satisfaction with an AI Wound Assessment Solution

Lyophilization

A Comparison of Lyophilized Amniotic Membrane with Cryopreserved Amniotic Membrane for the Reconstruction of Rabbit Corneal Epithelium is a comparison of the effect of cryopreserved amniotic membrane (CAM) with lyophilized amniotic membrane (LAM) on the reconstruction of rabbit corneal epithelium

News & Events

Stay ahead with the latest developments, breakthroughs, conferences and industry insights.

Entering a Golden Age: Advancements in Dry Eye Therapeutics October 12, 2023 Treatment Primer for Utilizing Amniotic Membrane Tissue September 30, 2023 More News

Oculus Biologics harnesses the healing power of the human body to optimize performance with an advanced processing technique called lyophilization.

“

It combines the best of both dehydrated and cryopreserved membranes …

… when you consider ease of use, storage, patient tolerance and corneal healing, which is why I was really interested in XcellerEYES.

Joaquin de Rojas, MD Director of Ocular Surface Disease & Cornea